JBCHEMICALSANDPHARMACEUT / Q2-FY26 / risks

Keep the risk register visible.

J B Chemicals · Material risks, their source context, and severity in the latest available quarter.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ2-FY26 · 2025-11-12Back to quarter ↗

Risk intelligence

Material risks this quarter

Acute seasonality impacting domestic growth

Muted acute season in Q2 affected legacy brands like Metrogyl and Rantac, leading to slower domestic growth. Future quarters may see similar variability.

medium

International formulation recovery uncertainty

International formulations grew only 2% in Q2 due to subdued South Africa and US markets. Management expects high single-digit growth in H2, but recovery is not guaranteed.

medium

ESOP charge overhang

Remaining ESOP charge of INR 47 Cr (INR 20 Cr in FY26, INR 27 Cr in FY27) will continue to impact reported profits, though excluded from operating EBITDA.

low